Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.

Autor: Einhorn LH (AUTHOR), Williams SD (AUTHOR), Chamness A (AUTHOR), Brames MJ (AUTHOR), Perkins SM (AUTHOR), Abonour R (AUTHOR)

Publikováno v: New England Journal of Medicine. 7/26/2007, Vol. 357 Issue 4, p340-348. 9p.

Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors.

Autor: Albany C; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. Electronic address: calbany@iu.edu., Adra N; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA., Snavely AC; PDstat, Chapel Hill, Indiana University School of Medicine, Indianapolis, USA., Cary C; Department of Urology, Indiana University School of Medicine, Indianapolis, USA., Masterson TA; Department of Urology, Indiana University School of Medicine, Indianapolis, USA., Foster RS; Department of Urology, Indiana University School of Medicine, Indianapolis, USA., Kesler K; Thoracic Division, Department of Surgery, Indiana University School of Medicine, Indianapolis, USA., Ulbright TM; Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA., Cheng L; Department of Pathology & Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA., Chovanec M; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA; 2nd Department of Oncology, Faculty of Medicine, Comenius University, Bratislava, USA; National Cancer Institute, Bratislava, Slovakia, USA., Taza F; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA., Ku K; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA; Division of Hematology & Medical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, USA., Brames MJ; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA., Hanna NH; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA., Einhorn LH; Division of Hematology & Medical Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Feb 01; Vol. 29 (2), pp. 341-346.

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

Autor: Adra N; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA. nadra@iu.edu., Albany C; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA., Brames MJ; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA., Case-Eads S; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA., Johnson CS; Department of Biostatistics, Indiana University, Indianapolis, IN, USA., Liu Z; Department of Biostatistics, Indiana University, Indianapolis, IN, USA., Fausel CA; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA., Breen T; Hoosier Cancer Research Network, Indianapolis, IN, USA., Hanna NH; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA., Hauke RJ; Methodist Hospital/Nebraska Cancer Specialists, Omaha, NE, USA., Picus J; Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, USA., Einhorn LH; Division of Hematology/Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN, 46202, USA.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2016 Jul; Vol. 24 (7), pp. 2837-42. Date of Electronic Publication: 2016 Feb 02.

Utilization of sperm banking and barriers to its use in testicular cancer patients.

Autor: Sonnenburg DW; Indiana University Simon Cancer Center, 535 Barnhill Drive, Indianapolis, IN, 46202, USA, dwsonnenburg@gmail.com., Brames MJ, Case-Eads S, Einhorn LH

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2015 Sep; Vol. 23 (9), pp. 2763-8. Date of Electronic Publication: 2015 Feb 15.